Table 5.
n | Concentrations | 95% CI | P To: TS | To: So | To: NTS | TS: So | TS: NTS | So: NTS | |
---|---|---|---|---|---|---|---|---|---|
C3 protein (RMSE: 35.4) | mg/dL | 0.011 | 2.6 × 10−5 | 0.18 | 0.19 | 0.26 | 0.011 | ||
1. To | 126 | 133.6 ± 37.8 | 127.0–140.3 | ||||||
2. TS | 110 | 121.8 ± 34.4 | 115.3–128.3 | ||||||
3. So | 180 | 116.1 ± 36.2 | 110.8–121.5 | ||||||
4. NTS | 104 | 127.3 ± 32.2 | 121.0–133.6 | ||||||
C4 protein (RMSE: 9.72) | mg/dL | 0.073 | 2.2 × 10−9 | 0.0004 | 0.0001 | 0.083 | 0.056 | ||
1. To | 126 | 23.7 ± 9.7 | 22.0–25.4 | ||||||
2. TS | 109 | 21.4 ± 11.5 | 19.2–23.6 | ||||||
3. So | 178 | 16.8 ± 9.0 | 15.5–18.1 | ||||||
4. NTS | 104 | 19.1 ± 8.8 | 17.4–20.8 | ||||||
C4A protein (RMSE: 6.12) | mg/dL | 0.247 | 1.9 × 10−6 | 0.017 | 0.0009 | 0.23 | 0.049 | ||
1. To | 126 | 12.5 ± 5.9 | 11.5–13.5 | ||||||
2. TS | 107 | 11.6 ± 7.6 | 10.1–13.0 | ||||||
3. So | 171 | 9.0 ± 5.6 | 8.2–9.9 | ||||||
4. NTS | 102 | 10.5 ± 5.6 | 9.5–11.6 | ||||||
C4B protein (RMSE: 5.46) | mg/dL | 0.045 | 1.3 × 10−6 | 0.0008 | 0.012 | 0.19 | 0.31 | ||
1. To | 126 | 11.2 ± 5.3 | 10.3–12.2 | ||||||
2. TS | 108 | 9.8 ± 6.7 | 8.5–11.0 | ||||||
3. So | 179 | 8.1 ± 4.9 | 7.4–8.8 | ||||||
4. NTS | 104 | 8.8 ± 5.2 | 7.8–9.8 | ||||||
CFH protein (RMSE:13.7) | mg/dL | 0.059 | 0.78 | 0.121 | 0.079 | 0.001 | 0.053 | ||
1. To | 111 | 51.5 ± 13.6 | 49.0–54.1 | ||||||
2. TS | 96 | 47.9 ± 9.7 | 46.0–49.9 | ||||||
3. So | 157 | 51.1 ± 14.6 | 48.8–53.4 | ||||||
4. NTS | 92 | 54.5 ± 15.4 | 51.3–57.7 | ||||||
MBL protein (RMSE: 0.154) | mg/dL | 0.95 | 0.0041 | 0.078 | 0.0046 | 0.076 | 0.42 | ||
1. To | 114 | 0.118 ± 0.140 | 0.092–0.144 | ||||||
2. TS | 100 | 0.117 ± 0.115 | 0.094–0.139 | ||||||
3. So | 152 | 0.173 ± 0.192 | 0.143–0.204 | ||||||
4. NTS | 90 | 0.157 ± 0.137 | 0.128–0.185 | ||||||
ACLA-IgM protein (RMSE: 35.7) | g/L | 0.28 | 0.0039 | 0.013 | 0.092 | 0.092 | 0.95 | ||
1. To | 101 | 16.8 ± 24.7 | 11.9–21.7 | ||||||
2. TS | 101 | 22.3 ± 39.9 | 14.4–30.1 | ||||||
3. So | 172 | 29.8 ± 39.5 | 23.9–35.8 | ||||||
4. NTS | 82 | 30.1 ± 33.4 | 22.8–37.5 | ||||||
ACLA-IgG protein (RMSE: 56.9) | g/L | 0.0063 | 1.2 × 10−5 | 0.058 | 0.17 | 0.488 | 0.041 | ||
1. To | 103 | 56.0 ± 87.7 | 38.9–73.1 | ||||||
2. TS | 103 | 34.3 ± 38.5 | 26.7–41.8 | ||||||
3. So | 170 | 24.5 ± 49.9 | 17.0–32.0 | ||||||
4. NTS | 84 | 40.1 ± 37.8 | 31.9–48.3 | ||||||
LAC-positivity (Frequency) | 0.65 | 0.0002 | 0.015 | 3.8 × 10−5 | 0.0048 | 0.39 | |||
1. To | 102 | 0.735 | |||||||
2. TS | 97 | 0.763 | |||||||
3. So | 172 | 0.512 | |||||||
4. NTS | 88 | 0.568 | |||||||
Sex (F/M ratio) | 0.0005 | 1.6 × 10−6 | 3.4 × 10−7 | 0.43 | 0.088 | 0.26 | |||
1. To | 126 | 2.07 | |||||||
2. TS | 111 | 6.40 | |||||||
3. So | 182 | 8.58 | |||||||
4. NTS | 106 | 14.1 |
p-values of statistical significance are in bold fonts.